Skip to main content

Retina and macula

Central serous retinopathy (CSR): symptoms, causes and treatment

Central serous retinopathy (CSR) is a common eye condition in which fluid collects under the macula, the part of the retina used for detailed central vision. It causes blurred or distorted vision, usually in one eye, and in most people it settles without treatment within a few months. This guide explains the symptoms, risk factors, tests and treatment options.

Last checked: 2026-10-10

Key facts

At a glance.

  • Fluid under the macula

    Moorfields says CSR occurs when fluid accumulates underneath the macula, leading to temporary blurring and distortion of vision.

  • Who is affected

    The Macular Society says it usually starts between ages 20 and 50 and affects six times more men than women. RNIB says it can also occur in older people.

  • Most settle on their own

    RNIB says for most people CSR gets better on its own and does not cause long-term changes to vision. Most recover within four to six months without treatment.

  • It can recur

    The Macular Society says CSR can come back and last longer than before, which happens in about 50% of people.

  • Steroids and stress

    Moorfields lists stress, corticosteroid use and a Type A personality as risk factors. The Macular Society and RNIB also mention Cushing syndrome, sleep apnoea and pregnancy.

  • Treat early if persistent

    RNIB says treatment may be considered after four to six months, or sooner if it recurs, and options include thermal laser and photodynamic therapy.

What CSR is

The macula is the central part of the retina and is responsible for sharp, detailed vision such as reading, recognising faces and driving. In CSR, RNIB explains, fluid leaks from behind the retina and collects under the macula, causing it to swell and the vision to be blurred and distorted. It usually occurs in one eye but can sometimes affect both.

The condition is also known as central serous chorioretinopathy (CSCR). The Macular Society says that sometimes the macula may lift up and become completely separated from the tissue behind it, and that the fluid can change how colour is seen.

Symptoms

Moorfields says the most common symptom is a blurred or distorted central vision in one eye. The Macular Society notes that not everyone has symptoms, that they can change from day to day, and that you should arrange to see an eye specialist as soon as you can if you notice changes.

  • Blurred central vision.

  • Straight lines that look wavy or distorted.

  • A dark grey patch or dark spot in the centre of vision.

  • Colours that look duller or less bright.

  • Objects that look smaller than they should (micropsia).

  • Increased sensitivity to light, or difficulty seeing an object against a similar background.

Causes and risk factors

RNIB says that in most cases doctors cannot find a cause, which is called idiopathic CSR. Moorfields likewise says the exact cause remains uncertain. Several factors are linked with it.

RNIB lists a Type A personality, steroid medication, pregnancy, Cushing syndrome, H. pylori infection, sleep apnoea and untreated high blood pressure. Cortisol, the stress hormone, is thought to be involved: RNIB says high cortisol over time can make blood vessels more fragile and leak, although it is not thought to be the only reason. Moorfields notes that steroids taken orally, inhaled or applied to the skin have been associated with CSR.

The Macular Society says some studies suggest that a family history raises the risk. The Macular Society advises minimising the use of corticosteroids if you can, and says never to stop taking a medicine without speaking to a doctor, as stopping suddenly can cause health problems.

How it is diagnosed

The Macular Society says it can be difficult to tell CSR apart from other eye conditions, so an eye specialist will run tests. An optical coherence tomography (OCT) scan, a painless 3D picture of the retina that can also be done at an optician, shows retinal thickness and fluid in the layers.

Other tests may include fluorescein angiography, in which a dye is injected into the arm to show where fluid is leaking from, and indocyanine green angiography. The Macular Society says the dye can stain the skin and colour the urine temporarily.

If you wait and see, repeat tests are used to check the fluid is going away.

Treatment and recovery

RNIB says most people with CSR do not need treatment and will be monitored as it recovers, usually within the first six months. Treatment may be recommended for CSR lasting longer than six months, according to RNIB, and the Macular Society says most people experience symptoms for four to six months and may need treatment if it does not go away after that.

Treatment options described by RNIB and the Macular Society
OptionWhat it doesPoints to know
Watch and waitMonitor while the fluid reabsorbsMost people recover within four to six months; repeat tests check the fluid is going
Photodynamic therapy (PDT)A laser treatment to close the leaking blood vesselsMay be considered if CSR persists beyond four to six months, or sooner if it recurs
Thermal or micropulse laserAims to help the retina reabsorb fluidRNIB says thermal laser cannot be used if the leak is too close to the centre of the macula
Anti-VEGF injectionsMedicine to stop blood vessels leakingListed by the Macular Society as an option
Reviewing medicinesReducing steroids where possibleOnly under medical advice, never by stopping suddenly

Outlook and living with CSR

RNIB says episodes of CSR that last a long time or keep coming back are more likely to cause permanent changes to vision, and that in a small number of people it becomes chronic, with damage to the retinal pigment epithelium. These treatments aim to reduce or resolve the fluid but cannot restore damaged cells.

The Macular Society suggests reducing stress, getting regular exercise and enough sleep, and minimising corticosteroid use where possible, and says that finding CSR early helps to prevent permanent changes. RNIB says that if the affected eye is your better eye you may need low vision aids or a low vision assessment, which you can ask your ophthalmologist, optometrist or GP about.

When to get help

Any sudden change in central vision should be assessed promptly. The Macular Society advises seeing an eye specialist as soon as you can. The Macular Society notes that an OCT scan can be done at an optician's practice, so a community optometrist is a sensible first step. If you lose vision suddenly, treat it as urgent and contact an optician, an eye casualty department or NHS 111 the same day.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What is central serous retinopathy?

    A retinal condition in which fluid collects under the macula. Moorfields says it leads to temporary vision blurring and distortion, mainly in people aged 20 to 50.

  • Will my sight return to normal?

    For most people, yes. RNIB says CSR gets better on its own for most people and does not cause long-term changes to vision, although long-lasting or repeated episodes are more likely to cause permanent changes.

  • How long does it last?

    The Macular Society says most people experience symptoms for four to six months. RNIB says most recover within four to six months without any need for treatment.

  • Can it come back?

    Yes. The Macular Society says CSR can recur and last longer than before, which happens in about 50% of people who get it.

  • Is stress a cause?

    Stress is a recognised risk factor. Moorfields lists psychological stress, and the Macular Society says stress raises cortisol, which can make CSR worse. It is not thought to be the only cause.

  • Do steroids cause CSR?

    They are linked with it. Moorfields says corticosteroids taken orally, inhaled or applied topically have been associated with CSR. Never stop prescribed steroids without speaking to your doctor.

  • What tests will I have?

    Typically an OCT scan, and sometimes fluorescein or indocyanine green angiography, according to the Macular Society. OCT can be done at an optician's practice.

  • What treatments are there?

    RNIB mentions thermal laser and photodynamic therapy. The Macular Society also lists anti-VEGF injections and micropulse laser. Most people do not need any treatment.

  • Can both eyes be affected?

    RNIB says it usually occurs in one eye but can sometimes affect both.

  • Who is most at risk?

    The Macular Society says men are affected six times more often than women, usually aged 20 to 50. RNIB lists steroid use, pregnancy, Cushing syndrome, sleep apnoea and untreated high blood pressure among associated factors.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-10, next review 2027-10-10.